Efficacy of intrabuccal ketamine for sedatio
Phase 3
Recruiting
- Conditions
- Oral procedure.
- Registration Number
- IRCT20180129038549N7
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Required oral procedures
Take informed consent
Exclusion Criteria
Sensitivity to benzodiazepines
Low blood pressure
Having a lung disease
Having Nervous-Muscular Disorders
Known contraindications to study drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation level of the patient. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.;Blood oxygen saturation level. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.;The time interval from taking the drugs to the adequate sedation. Timepoint: Every 5 minutes after drug administered. Method of measurement: Record time.;The time interval from taking the drug to the child's full consciousness. Timepoint: Every 5 minutes after drug administered. Method of measurement: Record time.;The parents' satisfaction. Timepoint: After the child's consciousness. Method of measurement: Question from parents.;Pulse rate per minute. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.;Respiratory rate per minute. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.